Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N, Thornalley PJ. Rabbani N, et al. Among authors: thornalley pj. Kidney Int. 2018 Apr;93(4):803-813. doi: 10.1016/j.kint.2017.11.034. Epub 2018 Feb 22. Kidney Int. 2018. PMID: 29477239 Review.
Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.
Westwood ME, McLellan AC, Thornalley PJ. Westwood ME, et al. Among authors: thornalley pj. J Biol Chem. 1994 Dec 23;269(51):32293-8. J Biol Chem. 1994. PMID: 7798229
Induction of synthesis and secretion of interleukin 1 beta in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts.
Westwood ME, Thornalley PJ. Westwood ME, et al. Among authors: thornalley pj. Immunol Lett. 1996 Apr;50(1-2):17-21. doi: 10.1016/0165-2478(96)02496-0. Immunol Lett. 1996. PMID: 8793554
Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.
Abordo EA, Westwood ME, Thornalley PJ. Abordo EA, et al. Among authors: thornalley pj. Immunol Lett. 1996 Oct;53(1):7-13. doi: 10.1016/0165-2478(96)02601-6. Immunol Lett. 1996. PMID: 8946211
Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.
Abordo EA, Thornalley PJ. Abordo EA, et al. Among authors: thornalley pj. Immunol Lett. 1997 Aug;58(3):139-47. doi: 10.1016/s0165-2478(97)00080-1. Immunol Lett. 1997. PMID: 9293394
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.
Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. Shinohara M, et al. Among authors: thornalley pj. J Clin Invest. 1998 Mar 1;101(5):1142-7. doi: 10.1172/JCI119885. J Clin Invest. 1998. PMID: 9486985 Free PMC article.
Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs.
Thornalley PJ. Thornalley PJ. Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1013-23. Cell Mol Biol (Noisy-le-grand). 1998. PMID: 9846883 Review.
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
Thornalley PJ, Langborg A, Minhas HS. Thornalley PJ, et al. Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):109-16. Biochem J. 1999. PMID: 10548540 Free PMC article.
Mass spectrometric monitoring of albumin in uremia.
Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A. Thornalley PJ, et al. Kidney Int. 2000 Nov;58(5):2228-34. doi: 10.1111/j.1523-1755.2000.00398.x. Kidney Int. 2000. PMID: 11044246
Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.
Thornalley PJ. Thornalley PJ. Int Rev Neurobiol. 2002;50:37-57. doi: 10.1016/s0074-7742(02)50072-6. Int Rev Neurobiol. 2002. PMID: 12198817 Review.
264 results
Jump to page
Feedback